Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript
Lifeward (LFWD) came out with a quarterly loss of $6.7 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $5.52 per share a year ago.
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript
| Health Care Technology Industry | Healthcare Sector | William Mark Grant CEO | XMUN Exchange | IL0011331076 ISIN |
| IL Country | 80 Employees | - Last Dividend | 24 Feb 2026 Last Split | - IPO Date |
Lifeward Ltd. is a pioneering medical device company founded by Amit Goffer on June 20, 2001, with its headquarters based in Marlborough, MA. Specializing in the design, development, and marketing of wearable robotic exoskeletons, the company focuses on innovative solutions to enhance mobility for individuals suffering from spinal cord injuries (SCI). Lifeward Ltd.’s mission revolves around leveraging advanced technology to enable users to stand upright, walk, turn, and navigate stairs with ease, thereby improving their quality of life and fostering greater independence.